SYN117 (nepicastat) + Placebo comparator
Phase 2Withdrawn 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post Traumatic Stress Disorder (PTSD)
Conditions
Post Traumatic Stress Disorder (PTSD)
Trial Timeline
Jun 1, 2008 → Nov 1, 2009
NCT ID
NCT00641511About SYN117 (nepicastat) + Placebo comparator
SYN117 (nepicastat) + Placebo comparator is a phase 2 stage product being developed by Johnson & Johnson for Post Traumatic Stress Disorder (PTSD). The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00641511. Target conditions include Post Traumatic Stress Disorder (PTSD).
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00641511 | Phase 2 | Withdrawn |
Competing Products
20 competing products in Post Traumatic Stress Disorder (PTSD)